Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elite Pharma Inc (ELTP)

Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information

Conference Call Scheduled for Monday, November 17 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)

Northvale, New Jersey--(Newsfile Corp. - November 12, 2025) - Elite Pharmaceuticals, Inc. (OTCBB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025

Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025Northvale, New Jersey--(Newsfile Corp. - November 10, 2025) - Elite Pharmaceuticals,...

ELTP : 0.4467 (+18.74%)
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth

Shares of Elite Pharmaceuticals, Inc. ELTP have gained 6.3% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 Index’s 1.1% loss over the same time...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information

Conference Call Scheduled for Friday, August 15 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - August 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

ELTP : 0.4467 (+18.74%)
2 Outperform Rated Small Caps with Recent Pull-backs

Here we highlight 2 small cap stocks with Zacks’ Outperform ratings that pulled back despite recent quarterly announcements which were arguably strong but a bit noisy.Elite Pharmaceuticals Inc. (ELTP)...

TSSI : 9.08 (+16.71%)
ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025

Financials for First Quarter of Fiscal Year 2026 Ended June 30, 2025 will be released on Thursday, August 14, 2025Northvale, New Jersey--(Newsfile Corp. - August 8, 2025) - Elite Pharmaceuticals, Inc. (OTCQB:...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 15.7% since the company reported its earnings for the fiscal year ended March 31, 2025. This compares to the S&P 500 Index’s 0.9% gain over the same...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, July 1 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - June 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

ELTP : 0.4467 (+18.74%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025

Financials for Fiscal Year 2025 Ended March 31, 2025 will be released on Monday, June 30, 2025Northvale, Northvale, New Jersey--(Newsfile Corp. - June 23, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP)...

ELTP : 0.4467 (+18.74%)

Barchart Exclusives

Should You Buy Uber Stock Now for a ‘Multitrillion-Dollar’ Opportunity in Robotaxis?
With management betting big on robotaxis as a future growth engine, should you buy Uber stock now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar